Baiju+Shah.jpeg

Baiju R. Shah, Chair of the Board of Managers

Mr. Shah is Chief Executive Officer of BioMotiv and co-leader of The Harrington Project for Discovery & Development. Prior to BioMotiv, he was President and CEO of BioEnterprise; during Mr. Shah's tenure, the initiative assisted in the creation, recruitment, and acceleration of more than 110 bioscience companies in Cleveland that collectively attracted $1.3 Billion in new funding. He has been named an Ernst & Young Entrepreneur of the Year and has been recognized as one of Cleveland's most influential leaders. He received a J.D. from Harvard Law School and a B.A. from Yale University.

Ted+Torphy.jpg

Ted Torphy, PhD, President

Ted Torphy, Ph.D., is the Chief Scientific Officer of BioMotiv and Board Chairman of the Cystic Fibrosis Foundation Therapeutics, Inc. Dr. Torphy brings over 30 years of experience in the pharmaceutical Industry, including at Johnson & Johnson and SmithKline Beecham, with a succcessful record in both small-molecule and large-molecule drug discovery and preclinical development. Dr. Torphy received his Ph.D. in Pharmacology and Toxicology from West Virginia University.